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CONCLUSION: Hepatic fibrosis due to BDL is not 
reduced by the HO-1 inducer CoPP. In contrast, HO-1 
overexpression increases liver injury in rats under 
conditions of experimental chronic cholestasis.
© 2007 WJG. All rights reserved.
Key words: Heme oxygenase-1; Bile duct ligation; 
Chronic cholestasis; Liver fibrosis; Serum alanine 
transaminase; Transforming growth factor-β; Tumor 
necrosis factor-Ⅰα; TypeⅠcollagen 
Froh M, Conzelmann L, Walbrun P, Netter S, Wiest R, Wheeler 
MD, Lehnert M, Uesugi T, Scholmerich J, Thurman RG. 
Heme oxygenase-1 overexpression increases liver injury 




Chronic cholestatic liver diseases are one of  the leading 
indications for liver transplantation in children and 
adults[1,2]. Various drugs, total parenteral nutrition, chronic 
liver transplant rejection, and graft-vs-host disease can also 
produce chronic cholestasis[3-5]. This leads to liver injury 
and will finally progress to portal fibrosis, cirrhosis and 
end-stage liver disease necessitating liver transplantation. 
Ursodeoxycholic acid is currently the most promising 
therapy for chronic cholestatic liver diseases[6]; however, 
it cannot prevent fibrosis[7]. How cholestasis induces 
liver injury and fibrosis remains unclear. One possible 
mechanism is that accumulation of  hydrophobic bile 
acids causes oxidative stress in the liver[8]. Previous studies 
showed that hepatic mitochondria generate reactive 
oxygen species when isolated hepatocytes are exposed to 
hydrophobic bile acids[8,9]. This mitochondrial free radical 
production may be an important mechanism of  cholestatic 
liver injury. However oxypurinol, an inhibitor of  xanthine 
oxidase, decreases hepatocelluar injury without decreasing 
lipid peroxidation in mitochondria and microsomes, 
suggesting that mitochondrial oxidative stress does not play 
an important role in cholestatic liver injury[10]. Therefore, 
the major source of  free radicals remains unclear. In biliary 
obstructed rats, hepatic glutathione levels and activities of  
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Abstract
AIM: To investigate the effects of heme oxygenase-1 
(HO-1) against oxidant-induced injury caused by bile 
duct ligation (BDL).
METHODS: Either cobalt protoporphyrin (CoPP), a 
HO-1 inducer, or saline were injected intraperitoneally in 
male SD-rats. Three days later, BDL or sham-operations 
were performed. Rats were sacrificed 3 wk after BDL 
and livers were harvested for histology. Fibrosis was 
evaluated by sirius red staining and image analysis. 
Alpha-smooth muscular actin, which indicates activation 
of stellate cells, was detected by immunohistochemical 
staining, and cytokine and collagen-Ⅰα (Col-Ⅰα) mRNA 
expression was detected using RNase protection assays.
RESULTS: Serum alanine transaminase increased 8-fold 
above normal levels one day after BDL. Surprisingly, 
enzyme release was not reduced in rats receiving CoPP. 
Liver fibrosis was evaluated 3 wk after BDL and the 
sirius red-positive area was found to be increased to 
about 7.8%. However, in CoPP pretreated rats sirius red-
positive areas were increased to about 11.7% after BDL. 
Collagen-Ⅰα and TGF-β mRNA increased significantly 
by BDL. Again, this effect was increased by HO-1 
overexpression.
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antioxidant enzymes decrease, whereas 4-hydroxynonenal 
and malondialdehyde levels increase[9,11,12]. These findings 
also support the involvement of  oxidative stress in 
cholestatic stress.
Heme oxygenases (HOs) are ubiquitous enzymes 
that catalyze the initial and rate-limiting steps in heme 
catabolism[13,14] yielding equimolar amounts of  biliverdin, 
carbon monoxide, and free divalent iron[15-18]. Biliverdin is 
subsequently reduced to bilirubin by biliverdin reductase, 
and the free iron is used in intracellular metabolism or 
sequestered into ferritin. The HO-system consists of  
three isoforms (HO-1, HO-2, and HO-3) as the products 
of  separate genes[14,19,20]. HO-1, also known as heat shock 
protein 32, is an inducible isoform activated by most 
oxidative stress inducers and cytokines[17]. Constitutively 
expressed HO-2 is unresponsive to any of  the known 
HO-1 inducers[17,20,21]. The HO-3 isozyme has 90% 
homology in the amino acid sequence with HO-2 and is 
nearly devoid of  catalytic activity, serving mainly as heme-
sensing/binding protein[19]. The mechanism by which 
HO-1 confers protection against oxidative stress has not 
yet been fully understood. It has been suggested that 
HO-1 possesses antioxidant activity deriving from the 
elimination of  prooxidant heme and from the biological 
activities of  its reaction products: biliverdin, bilirubin and 
iron[22-24]. Both biliverdin and bilirubin possess antioxidant 
properties[25], whereas iron released during heme catabolism 
can stimulate ferritin synthesis[26].
This study was designed to test whether an increased HO-1 
expression by the HO-1 inducer cobalt protoporphyrin (CoPP) 
would minimize oxidative stress caused by experimental 
cholestasis and thereby decrease liver fibrosis.
MATERIALS AND METHODS
Animal husbandry and treatment
Adult male Sprague-Dawley rats (200-250 g) were housed 
four to a cage in a facility approved by the Association 
for the Accreditation and Assessment of  Laboratory 
Animal Care International. Three days before surgery, 
rats were randomly assigned to two experimental groups 
and received either 0.5 mL of  lactated Ringer's solution 
or CoPP (Frontier Scientific Inc., Logan, UT, USA) at a 
concentration of  5 mg/kg diluted in 0.5 mL of  lactated 
Ringer's solution intraperitoneally. After surgery, rats were 
allowed free access to standard laboratory chow and tap 
water. All animals received humane care in compliance 
with guidelines approved by the Institutional Animal Care 
and Use Committee of  the University of  North Carolina 
at Chapel Hill.
Bile duct ligation
Rats underwent bile duct ligation (BDL) and transection 
or sham operation under ether anesthesia, as described 
elsewhere[27].
Clinical chemistry and histology
Blood samples were collected from the tail vein at times 
indicated in Figure 1. Serum enzymes were measured 
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using analytic kits from Sigma (St. Louis, MO, USA). For 
histology, the liver was rinsed with normal saline, followed 
by slow infusion of  5 mL 10% buffered formaldehyde. 
After 48 h in fixative, paraffin sections were prepared and 
stained with hematoxylin-eosin or 0.1% Sirius red and 
Fast green FCF (Sigma)[28]. Areas in sections stained for 
collagens by Sirius red were quantified by image analysis 
using an Universal Imaging Image-1/AT image acquisition 
and analysis system (West Chester, PA, USA) incorporating 
an Axioskop 50 microscope. Detection thresholds were set 
for the red color of  stained collagen based on an intensely 
labeled point and a default color threshold range that 
was assigned. The degree of  labeling in each section was 
determined from the area within the color range divided 
by the total cellular area.
Immunohistochemistry for α-smooth muscle actin
Immunohistochemistry for α-smooth muscle actin 
(α-SMA) was performed on 6 μm sections of  formalin-
fixed, paraffin-embedded liver-sections according to 
the supplier's instructions. Sections were deparaffinized 
in xylene, rehydrated in a series of  graded alcohol 
concentrations, and placed in phosphate-buffered 
saline with 1% Tween 20. Staining was performed with 
monoclonal primary antibodies (DAKO, Carpinteria, CA, 
USA) against α-SMA and followed by peroxidase labeling 
using an EnVision kit (DAKO). The primary antibody 
was diluted 1:200 with 1% bovine albumin (Sigma) in 
phosphate-buffered saline. After immunohistochemistry, 
samples were lightly counterstained with hematoxylin.
Protein isolation and Western blotting
Whole liver tissue was homogenized in lysis buffer with 
protease inhibitors at 4℃. The supernatant was collected 
and used as the source of  protein for Western blots, as 
described elsewhere[29,30]. Protein was analyzed using a 
1:1000 dilution of  anti-HO-1 polyclonal antibody (Santa 
Cruz Biotechnology, Santa Cruz, CA, USA) and a 1:5000 
dilution of  horseradish peroxidase-conjugated antibody 




















Figure 1   Experimental design. Either CoPP or sal ine were injected 
intraperitoneally in male rats. Three days later, bile duct ligation (BDL) or sham 
operation was performed. Some animals were killed 3 d after CoPP injection or 
3 wk after BDL to assess HO-1 protein expression in liver tissue. Blood samples 
were taken just before and at 0, 1, 7, 14, and 21 d after BDL to assess for 
alanine transaminase (ALT), aspartate aminotransaminase (AST), serum alkaline 
phosphatase (ALP), and bilirubin. Liver sections were taken from rats 3 wk after 
BDL to evaluate pathological changes.
AP-1 and NF-κB determination using EMSA
Measurement of  AP-1 and NF-κB by EMSA was 
performed, as described in detail elsewhere[29-31]. 
RNase protection assay for collagen-Ⅰα , TNF-α , and 
transforming growth factor-β mRNA
Total RNA was isolated from liver tissue using RNA 
STAT 60 (Tel-Test, Friendswood, TX, USA). The RNA 
was extracted and purified following standard phenol/
chloroform extraction and ethanol precipitation. RNase 
protection assays were performed using the RiboQuant 
multiprobe assay system (Pharmingen, San Diego, CA, 
USA) or an individual probe[29,30]. Gels were visualized 
by autoradiography[32]. Bands corresponding to the 
protected labeled fragment were quantitated by scanning 
densitometry software (ImageQuant 5.0), and where 
statistical data are given, they were normalized to the level 
of  GAPDH as the housekeeping gene.
Statistical analysis
Data are presented as mean ± SD. ANOVA and the 
Student-Newman-Keuls post hoc tests were used to 
determine statistical significance between treatment 
groups. A P value less than 0.05 was selected before the 
study as the level of  significance.
RESULTS
Expression of HO-1 in the liver
Experimental design is depicted in Figure 1. To confirm 
that CoPP pretreatment induced HO-1 overexpression, 
HO1 protein expression in whole livers was studied by 
immunoblotting analysis. As expected, HO-1 protein 
was identified in saline pretreated rats 3 wk after BDL 
(Figure 2), confirming previously published data[33]. Almost 
no HO-1 protein signal was detected in sham-operated 
rats pretreated with saline (Figure 2). In contrast, CoPP 
pretreatment produced a strong HO-1 protein signal in 
sham-operated and bile duct-ligated rats, indicating an 
increased HO-1 expression thru CoPP (Figure 2).
Serum enzymes and histology
In untreated rats that were fed a standard chow diet, 
serum alanine aminotransaminase (ALT) levels averaged 
70 U/L (Figure 3) and were not significantly altered by 
CoPP pretreatment and sham operation. After BDL, ALT 
increased to 386 U/L after 1 d (Figure 3), indicating liver 
injury. ALT levels decreased afterward and reached a new 
steady-state level of  about 80 U/L after 1 wk (Figure 3). 
When rats were pretreated with the HO-1 inducer CoPP, 
ALT levels increased to 472 U/L one day after BDL 
(Figure 3). ALT levels decreased also afterward and 
reached a steady-state level of  about 110 U/L after 1 wk 
before they significantly increased to 148 U/L after 3 wk 
(Figure 3).
Normal liver architecture was observed after saline 
or CoPP pretreatment and sham operation (Figure 4A). 
Three weeks after BDL characteristic morphology 
of  obstructive biliary cirrhosis, including bile duct 
proliferation, diffuse micronodules, focal necrosis and 
white blood cell infiltration were observed in livers from 
rats receiving saline pretreatment (Figure 4B). These 
pathological changes were increased by rats receiving 
CoPP pretreatment (Figure 4C). 
Fibrogenesis in the liver
To evaluate the effects of  HO-1 overexpression on liver 
fibrosis after BDL, liver sections were stained with Sirius 
red for collagen. Independently of  pretreatment (saline 
or CoPP), no fibrosis was observed in livers from sham-
operated rats (Figure 5A). In rats receiving normal saline, 
hepatic fibrosis developed within 2 wk after BDL (data not 
shown) and was severe after 3 wk (Figure 5B). When rats 
pretreated with CoPP were subjected to BDL, histology 
revealed increased fibrosis (Figure 5C). Image analysis 
revealed that Sirius red stained an area of  about 0.7% of  
liver sections from sham-operated rats, independently of  
pretreatment (Figure 6). Sirius red staining increased to 
7.8% after 3 wk following BDL (Figure 6). Pretreatment 
with CoPP raised this increase in Sirius red staining 
significantly after BDL to 11.7% of  the measured areas 
(Figure 6).
Collagen gene expression was evaluated by RNase 
protection assay for collagen-Iα mRNA and was barely 
detectable in livers from sham-operated rats, independently 
of  pretreatment (Figure 7A). Three weeks after BDL, 
however, collagen-Ⅰα mRNA expression increased to 
about 2000% compared with sham-operated groups 
HO-1 protein
    (32 kDa)
Sham CoPP BDL BDL + CoPP
Treatment
→
Figure 2  Immunodetection of HO-1 in liver tissues 3 wk after BDL or sham 
operation. The expression of HO-1 using an anti-HO-1 polyclonal antibody was 
determined by Western blot. Data are representative of 4 to 6 animals per group. 
Figure 3  Time course of alanine transaminase (ALT) release after BDL or sham 
operation. BDL or sham operation were performed 3 d after CoPP or saline 
injection, and blood samples were collected at time points indicated in the figure. 
Serum ALT activity was determined using commercial kits from Sigma. Values are 
means ± SD (n = 5-6 in each group). aP < 0.05 vs bile duct-ligated group receiving 
saline.
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(Figure 7A and B). Pretreatment with CoPP worsen the 
increase in collagen-Ⅰα mRNA expression to about 
3000% (Figure 7A and B).
Immunohistochemical staining for α-SMA
Activated stellate cells are the major source of  matrix 
proteins in diseased liver[34]. Accordingly, we evaluated 
α-SMA, an indicator of  stellate cell activation, by 
immunohistochemical staining after BDL. In livers from 
sham-operated rats (independently of  pretreatment), 
small amounts of  α-SMA were detected in the smooth 
muscle and endothelium of  blood vessels (Figure 8A). 
After BDL, α-SMA increased markedly in perisinusoidal 
cells consistent with stellate cell activation in cholestatic 
livers (Figure 8B). Again, HO-1 overexpression by CoPP 
treatment before BDL significantly increased the amount 
of  α-SMA-positive areas, indicating an increase of  stellate 
cell activation (Figure 8C).
Transcription factors and cytokine expression in the liver 
NF-κB/DNA complexes were barely detectable in livers 
from sham-operated rats (independently of  pretreatment) 
but increased around 3.5-fold after BDL, consistent with 
our previous studies[29,30]. CoPP pretreatment did not 
suppress this activation (data not shown). A small amount 
of  AP-1/DNA complex was detected in livers from sham-
operated rats. Three weeks after BDL, however, AP-1/
DNA complex levels increased around 2-fold, indicating 
activation of  AP-1[29,30]. Again, HO-1 overexpression thru 
CoPP pretreatment did not suppress this activation (data 
not shown).
Minimal amounts of  TGF-β1 mRNA were detected in 
A  Sham
B  BDL
C  BDL +
      CoPP
Figure 4  Effects of HO-1 overexpression on hepatic pathology changes caused by 
BDL. Rats were pretreated with CoPP or saline. Livers were harvested 3 wk after 
BDL, and hematoxylin and eosin staining was performed to evaluate pathological 
changes. Shown are representative images (x 40). A: sham operation with saline 
pretreatment; B: BDL with saline pretreatment; C: BDL with CoPP pretreatment.
A  Sham
B  BDL
C  BDL +
      CoPP
Figure 5  Effects of HO-1 overexpression on hepatic fibrosis after BDL. Rats were 
pretreated with CoPP or saline. Livers were harvested 3 wk after BDL, and Sirius 
red staining of sections was performed. Shown are representative images (x 40). A: 
sham operation with saline pretreatment; B: BDL with saline pretreatment; C: BDL 
with CoPP pretreatment.
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livers from rats after sham operation. After BDL, TGF-β1 
mRNA expression significantly increased by around 
threefold (Figure 9A and B). CoPP pretreatment did not 
suppress these increases in TGF-β expression. In contrast, 
TGF-β1 mRNA expression was even more increased in 
rats receiving CoPP before BDL (Figure 9B). TNF-α 
mRNA was barely detectable in livers from sham-operated 
rats (Figure 9A and C) but was increased around twofold 
after BDL. HO-1 overexpression thru CoPP pretreatment 
did not suppress this increase in TNF-α mRNA expression 
(Figure 9C).
DISCUSSION
Cholestasis leads to liver injury and will finally progress 
to fibrosis necessitating liver transplantation[1,35]. Current 
therapy for cholestasis, such as ursodeoxycholic acid, 
does not prevent fibrosis[7]. Therefore, new strategies to 
prevent cholestasis-induced liver injury and fibrosis are 
needed. Previous work suggest that oxidative stress occurs 
during cholestasis and probably plays a role in cholestasis-
induced liver injury[8,9,36]. Accordingly, antioxidant therapy 
represents a potential strategy to prevent liver injury and 
fibrosis. 
There are several reports suggesting protective effects 
of  HO-1 against oxidant-induced injury and the induction 
of  HO-1 as an adaptive response against oxidative damage. 
In detail, HO-1 overexpression can protect steatotic rat 
liver from ischemia reperfusion injury[37], prolong cardiac 
allograft[38], prevent arteriosclerosis and cardiac fibrosis in 
cardiac transplantation[39], be neuroprotective[40], attenuate 
chronic rejection of  renal transplantation[41], and protect 
animals from endotoxic shock[42]. Based on this data, 
we assumed that HO-1 overexpression leading to less 
oxidative damage reduced cholestasis-induced liver injury 
and fibrosis. Accordingly, we assessed the effect of  CoPP, a 
HO-1 inducer, leading to a stable HO-1 overexpression[37] 
in a rat model of  cholestasis induced by BDL.
CoPP-induced HO-1 overexpression increases liver injury 
and hepatic fibrosis due to BDL
In confirmation of  previous work from our and several 
other laboratories[11,12,27,29,30], BDL caused hepatic ALT 
release (Figure 3), cell necrosis (Figure 4) and fibrosis 
(Figures 5-7) as expected. Surprisingly, enzyme release 
and histopathological changes were not reduced in 
rats receiving CoPP. Moreover, a significant increase in 
ALT levels (Figure 3) and pathology (Figure 4) could be 
demonstrated 3 wk after BDL for CoPP pretreated vs 
bile duct-ligated rats receiving saline. Furthermore, HO-1 
overexpression significantly deteriorated fibrosis caused by 
cholestasis, as shown by Sirius red staining and collagen-Ⅰ
α mRNA expression (Figures 5-7).


































Figure 6  Quantification of hepatic fibrosis after BDL. Liver sections were stained 
with Sirius red, as described in Figure 4. Five microscope fields (x 40 objective) 
were selected randomly, and fractional areas that were Sirius red positive were 
determined by image analysis. Values are means ± SD (n = 5-6 in each group). 
aP < 0.05 vs sham-operated groups, CP < 0.05 vs bile duct-ligated group receiving 
saline.












































Figure 7  Effects of cholestasis and HO-1 overexpression on collagen-Iα mRNA 
expression. Livers were harvested 3 wk after BDL, perfused with normal saline, 
and frozen in liquid nitrogen. RNase protection assays were performed using 
an individual probe. Values are means ± SD (n = 4 in each group). Specific 
bands were quantitated by scanning densitometry and normalized to the signal 
of GAPDH. A: representative autoradiogram of collagen-Iα mRNA expression; 
B: densitometric analysis of collagen-Iα mRNA expression. aP < 0.05 vs sham-
operated groups, CP < 0.05 vs bile duct-ligated group receiving saline.
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How does HO-1 overexpression increase 
cholestasis-induced liver fibrosis? 
Beside protect ive effects of  upregulat ion of  the 
HO-1 pathway there i s increas ing ev idence that 
HO-1 overexpression and activity is not exclusively 
cytoprotective. Recent studies indicate that the protection 
might be restricted to a narrow threshold of  HO-1 
overexpression[43-46]. High levels of  HO-1 may even 
sensitize the cell to oxidative stress, as demonstrated in 
fibroblast cell cultures, where low HO-1 induction was 
shown to be cytoprotective, whereas excessive activation 
of  HO-1 resulted in the accumulation of  free divalent 
iron and increased oxidative injury[43]. Moreover, increased 
HO-1 expression was shown in human NASH patients, 
reflecting the severity of  the disease and the progression 
of  liver failure[44]. Furthermore, a dual role for HO-1 
A  Sham
B  BDL
C  BDL +
      CoPP
Figure 8  Effects of HO-1 overexpression on α-smooth muscle actin (α-SMA) 
formation after BDL. Livers were harvested 3 wk after BDL, and sections were 
stained immunohistochemically to assess α-SMA. Shown are representative 
images (x 40). A: sham operation with saline pretreatment; B: BDL with saline 
pretreatment; C: BDL with CoPP pretreatment.
Figure 9  Effects of cholestasis and HO-1 overexpression on production of TGF-β 
and TNFα. Livers were harvested 3 wk after bile duct ligation and snap-frozen in 
liquid nitrogen. TGF-β and TNFα mRNAs were assessed by RNase protection 
assay using cytokine template sets, as described in MATERIAL AND METHODS. 
Values are means ± SD (n = 4 in each group). Specific bands were quantitated by 
scanning densitometry and normalized to the signal of GAPDH. A: representative 
autoradiogram of TGF-β and TNFα mRNA expression; B: densitometric analysis 
of TGF-β1 mRNA expression. aP < 0.05 vs sham-operated groups, bP < 0.05 vs 
bile duct-ligated group receiving saline; C: densitometric analysis of TNFα mRNA 
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expression in human liver transplants, with either cytopro-
tection or increased cytotoxicity, depending on the initial 
level of  overexpression could be demonstrated[45]. These 
results point towards the potentially different effects of  
HO-1, which may be neither exclusively cytoprotective nor 
exclusively cytotoxic.
Normally, factors of  an increased HO-1 expression in 
a model of  experimental cirrhosis may include NO and 
oxidative stress[9,47,48], as well as especially increased cytokine 
and endotoxin levels[49]. It is known, that HO-1 expression 
and activity is greatly enhanced in cirrhotic rat livers[33,50,51], 
suggesting an important role in cirrhosis development. In 
BDL livers, HO-1 was induced especially in hepatocytes 
but it was also enhanced in Kupffer cells[33,51]. Accordingly, 
the additionally exogenous induction of  HO-1 in a model 
of  hepatic fibrosis due to BDL could further increase an 
already elevated HO-1 expression, resulting in potentially 
detrimental effects instead of  cytoprotection.
Oxidant-induced cell death may also cause exaggerated 
repair leading to fibrosis. Therefore, non-prevention 
of  cell death may increase subsequent fibrosis. There 
are numerous reports indicating anti-apoptotic abilities 
of  HO-1[39,52-54] by suppressing one or several signaling 
pathways of  the pro-apoptotic stimuli. In contrast to these 
findings, we found that HO-1 overexpression increased 
ALT release and necrosis of  parenchymal cells (Figures 3 
and 4), as well as maximizing fibrosis (Figures 5-7) in this 
model of  chronic cholestasis due to BDL. 
Activation of  hepatic stellate cells appears to be 
a critical step in hepatic fibrogenesis that is regulated 
by several factors, including cytokines and oxidative 
stress[34,55,56]. Previous studies could demonstrate HO-1 
overexpression as a negative regulator in the control of  
fibrogenic activities of  hepatic stellate cells[57,58]. Therefore 
it was hypothesized that HO-1 overexpression may 
prevent fibrosis by inhibiting oxidant-dependent activation 
and proliferation of  stellate cells. In contrast to this 
hypothesis, α-SMA, a marker of  stellate cell activation, 
dramatically increased after BDL (Figure 8), an effect that 
was significantly worsen by CoPP pretreatment. Activated 
stellate cells also produce TGF-β1, which causes further 
proliferation of  stellate cells and strongly stimulates 
production of  collagens[59,60]. Oxidative stress not only 
increases production of  TGF-β1 but also activates latent 
TGF-β1[61,62]. Additionally, H2O2 activates transcriptional 
factors such as AP-1 and NF-κB[63] that are involved 
in stellate cell activation and synthesis of  TGF-β1[55,63]. 
Consistent with these earlier findings, activation of  
AP-1, NF-κB, and increases in TGF-β1 mRNA were 
all observed in the present study after BDL (Figure 9), 
supporting the hypothesis that oxidative stress stimulates 
TGF-β1 production, leading to collagen gene and protein 
expression (Figure 7). But in contrast, CoPP pretreatment 
before BDL did not blocked activation of  transcription 
factors and cytokine production. Furthermore, HO-1 
overexpression induced TGF-β1 (Figure 9B) expression 
after BDL even more, leading to a significant increase 
in collagen-Ⅰα mRNA and α-SMA protein expression 
(Figures 7 and 8). These findings also point to the 
potential pro-oxidant consequences of  an increased HO-1 
expression and activity.
Another possibility is that elevated HO-1 over-
expression aggravates the activation of  Kupffer cells, thus 
increasing formation of  inflammatory and fibrogenic 
mediators. Previous reports identified Kupffer cells as 
the main source of  HO-1 expression in human livers[45,64] 
in contrast to controversial data from rat livers, where 
considerable expressions of  HO-1 has also been found 
in hepatocytes[51,65]. Besides the large body of  evidence 
demonstrating cytoprotective effects of  HO-1 upregulation 
in transplant models in animals[37,66,67], Geuken et al[45] sug-
gested that high HO-1 overexpression in Kupffer cells in 
human liver allografts may contribute to an increased cell 
injury. In general, the role of  Kupffer cells in fibrosis is 
controversial. Destruction of  Kupffer cells attenuated liver 
fibrosis caused by carbon tetrachloride[68]. By contrast, in a 
rat model of  reversible biliary obstruction, inactivation of  
Kupffer cells impaired collagen metabolism and inhibited 
the resolution of  fibrosis[69]. Kupffer cells release many 
mediators that activate stellate cells, including TNF-α, 
TGF-β, human growth factor, PDGF, and reactive oxygen 
species[60,70]. TNF-α production and NF-κB activation 
increase during cholestasis[71,72]. Activation of  NF-κB, 
probably due to oxidative stress, could lead to expression 
of  TNF-α. An inhibition of  proinflammatory cytokine 
production as a result of  HO-1 overexpression, as 
reported for several other liver injury models[73-75], could 
not be demonstrated in the present study. In addition, we 
have shown that activation of  NF-κB and expression of  
TNF-α and TGF-β were increased by cholestasis and that 
these effects were not blocked by HO-1 overexpression 
(Figure 9). In contrast, TGF-β1 mRNA expression was 
significantly increased in rats receiving CoPP before BDL 
(Figure 9B) demonstrating an additional accumulation of  
one key mediator in fibrogenesis. However, in a previous 
study we could demonstrate that suppression of  Kupffer 
cell function with GdCl3, a treatment that blocks carbon 
tetrachloride-induced fibrosis[68], did not attenuate fibrosis 
caused by cholestasis[29]. This might indicate that Kupffer 
cells likely do not play a prominent role in cholestasis-
induced fibrosis in vivo and that HO-1 up-regulation does 
not work exclusively by increasing Kupffer cell activation.
I n c o n c l u s i o n , we c o u l d d e m o n s t r a t e t h a t 
hepatic fibrosis due to BDL is not reduced by HO-1 
overexpression. In contrast, CoPP dependent HO-1 
overexpression increases liver injury in rats under 
conditions of  experimental chronic cholestasis. In 
conjunction with previous reports, these findings indicate 
that increased HO-1 activity is not exclusively protective. 
Rather, the HO-1 induced cytoprotection might be 
restricted to a narrow threshold of  overexpression in the 
injury model used.
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